Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
- Resource Type
- Journal
- Authors
- Barrett, Jordan R.; Belij-Rammerstorfer, Sandra; Dold, Christina; Ewer, Katie J.; Folegatti, Pedro M.; Gilbride, Ciaran; Halkerston, Rachel; Hill, Jennifer; Jenkin, Daniel; Stockdale, Lisa; Verheul, Marije K.; Aley, Parvinder K.; Angus, Brian; Bellamy, Duncan; Berrie, Eleanor; Bibi, Sagida; Bittaye, Mustapha; Carroll, Miles W.; Cavell, Breeze; Clutterbuck, Elizabeth A.; Edwards, Nick; Flaxman, Amy; Fuskova, Michelle; Gorringe, Andrew; Hallis, Bassam; Kerridge, Simon; Lawrie, Alison M.; Linder, Aline; Liu, Xinxue; Madhavan, Meera; Makinson, Rebecca; Mellors, Jack; Minassian, Angela; Moore, Maria; Mujadidi, Yama; Plested, Emma; Poulton, Ian; Ramasamy, Maheshi N.; Robinson, Hannah; Rollier, Christine S.; Song, Rinn; Snape, Matthew D.; Tarrant, Richard; Taylor, Stephen; Thomas, Kelly M.; Voysey, Merryn; Watson, Marion E. E.; Wright, Daniel; Douglas, Alexander D.; Green, Catherine M.; Hill, Adrian V. S.; Lambe, Teresa; Gilbert, Sarah; Pollard, Andrew J.; Oxford COVID Vaccine Trial Grp
- Source
- NATURE MEDICINE; DEC 17 2020, 28p.
- Subject
- Language
- English
- ISSN
- 1546170X